SARS and MERS: recent insights into emerging coronaviruses
E De Wit, N Van Doremalen, D Falzarano… - Nature reviews …, 2016 - nature.com
Abstract The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in
2012 marked the second introduction of a highly pathogenic coronavirus into the human …
2012 marked the second introduction of a highly pathogenic coronavirus into the human …
A review of treatment modalities for Middle East Respiratory Syndrome
The Middle East Respiratory Syndrome coronavirus (MERS-CoV) has been a focus of
international attention since its identification in 2012. Epidemiologically it is characterized by …
international attention since its identification in 2012. Epidemiologically it is characterized by …
[HTML][HTML] Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia
We explored the feasibility of collecting convalescent plasma for passive immunotherapy of
Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using ELISA to …
Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using ELISA to …
IVIG in autoimmune disease—Potential next generation biologics
AW Zuercher, R Spirig, AB Morelli, F Käsermann - Autoimmunity reviews, 2016 - Elsevier
Polyclonal plasma-derived IgG is a mainstay therapeutic of immunodeficiency disorders as
well as of various inflammatory autoimmune diseases. In immunodeficiency the primary …
well as of various inflammatory autoimmune diseases. In immunodeficiency the primary …
Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance
SM Opal - Critical Care, 2016 - Springer
The emergence of multi-drug resistant (MDR) microbial pathogens threatens the very
foundation upon which standard antibacterial chemotherapy is based. We must consider …
foundation upon which standard antibacterial chemotherapy is based. We must consider …
Passive transfer of a germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal Middle East respiratory syndrome coronavirus …
AS Agrawal, T Ying, X Tao, T Garron, A Algaissi… - Scientific reports, 2016 - nature.com
Abstract Middle East Respiratory Syndrome coronavirus (MERS-CoV) has repeatedly
caused outbreaks in the Arabian Peninsula. To date, no approved medical countermeasures …
caused outbreaks in the Arabian Peninsula. To date, no approved medical countermeasures …
[HTML][HTML] Development of medical countermeasures to Middle East respiratory syndrome coronavirus
TM Uyeki, KJ Erlandson, G Korch… - Emerging infectious …, 2016 - ncbi.nlm.nih.gov
Preclinical development of and research on potential Middle East respiratory syndrome
coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are …
coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are …
[HTML][HTML] An effective DNA vaccine platform for Middle East respiratory syndrome coronavirus
AS Cockrell, RS Baric - Annals of Translational Medicine, 2016 - ncbi.nlm.nih.gov
Middle East respiratory syndrome coronavirus (MERS-CoV) is an ongoing emerging
infectious disease across the Arabian Peninsula, with the majority of cases occurring in …
infectious disease across the Arabian Peninsula, with the majority of cases occurring in …
[HTML][HTML] The search for therapeutic options for Middle East Respiratory Syndrome (MERS)
More than three years after the first case was described, Middle East Respiratory Syndrome
(MERS) coronavirus continues to cause sporadic cases in the community as well as …
(MERS) coronavirus continues to cause sporadic cases in the community as well as …
Cattle engineered to produce human antibodies against coronavirus
N Bray - Nature Reviews Drug Discovery, 2016 - nature.com
Passive immunotherapy—for example, using specific antibodies—may represent a good
possible treatment strategy against Middle East respiratory syndrome coronavirus (MERS …
possible treatment strategy against Middle East respiratory syndrome coronavirus (MERS …